Zhongchao Inc. Investment Overview: What You Need to Know

Thinking about investing in Zhongchao Inc.? Before you put your money on the line, let’s break down what this company does and the risks involved in plain English.

1. What does this company actually do?

Zhongchao acts as a digital bridge between medical professionals and the healthcare industry in China. Their "MDMOOC" platform provides training, education, and clinical guidance to doctors, nurses, and medical students.

They also run "patient-aid programs" that help patients with cancer or rare diseases access medicine and financial support. By connecting doctors with pharmaceutical companies, Zhongchao helps those companies share research and product information with specific medical audiences.

2. How do they make money?

Zhongchao earns money through three main services:

• Medical Education: Charging companies to host webinars, training modules, and educational content.
• Marketing: Helping pharmaceutical companies promote their products to medical professionals.
• Patient-Aid Programs: Managing administrative tasks and data for programs that connect patients with drug manufacturers.

A recent shift: The company stopped its wholesale drug distribution business in June 2025. They are now focusing entirely on their digital education and service platform.

3. What is this new offering about?

As of May 2026, Zhongchao is selling "units" to investors. Each unit includes one Class A share (or a pre-funded warrant) and one warrant to buy another share later.

• The Price: They set an assumed price of $2.16 per unit.
• The Warrants: These act like coupons. They let you buy more Class A shares at a price equal to 110% of the unit price. You can use these immediately, and they expire in five years.

4. Important Updates: Share Consolidation and Voting Power

The company recently changed its financial structure:

• Share Consolidation: In March 2026, the company performed a "1-for-8" reverse stock split to meet NASDAQ’s minimum price requirements.
• Voting Power: The company uses two classes of shares. Class B shares, held by the founder and management, have 1,000 votes each. Your Class A shares have only 1 vote each. This means the founder keeps total control over all major company decisions.

5. The "VIE" Structure: A Very Important Detail

This is crucial: You are not buying a direct piece of a Chinese company. Zhongchao is a Cayman Islands holding company. Because China restricts foreign investment in certain internet sectors, Zhongchao uses a "Variable Interest Entity" (VIE) structure. You own shares in a Cayman shell company that has contracts with the actual business in China. If the Chinese government decides these contracts are illegal, your investment could become worthless.

6. What are the main risks?

• Legal Hurdles: As a foreign company, Zhongchao is subject to Chinese law. It is very difficult for U.S. investors to sue the company or enforce U.S. court judgments in China.
• No Say: Because Class B shares have so much voting power, public shareholders have no real influence over how the company is run.
• Data Privacy: The company manages data for about 200,000 medical professionals. They must follow strict Chinese cybersecurity rules. If they fail a government review, the government could shut down their online platforms.
• No Dividends: The company has a history of losses. They plan to keep all future earnings to grow the business, so do not expect any dividend payments.

Final Thoughts for Investors

This investment is highly speculative. Between the complex "VIE" structure, the founder's total control, and the regulatory risks in China, this is not a standard stock purchase.

Before you buy:

1. Check your risk tolerance: Can you afford to lose the entire investment if the regulatory environment in China shifts?
2. Review the "VIE" risk: Ensure you are comfortable owning a contract-based interest rather than direct equity in the Chinese operations.
3. Consider the control: Remember that as a Class A shareholder, you have no meaningful vote in the company's direction.

Disclaimer: I am an AI, not a financial advisor. This guide is for informational purposes only. Always do your own research or consult with a qualified professional before making investment decisions.